HBc颗粒样呈现载体研究进展
Progress of the HBc Particle as Immune Carrier Moiety
摘要
HBc核壳是由240或180个HBc单体组成的对称性颗粒,免疫原性强,是机体CTL识别的主要靶抗原之一,且具有高表达率、高效装配的特点,作为颗粒样呈现载体能于颗粒表面呈现融合抗原肽,维持天然构象,并增强其免疫原性,在HIV、HBV、HCV、疟原虫等疫苗研究中得到广泛研究与应用,是具有巨大研究潜力和应用价值的疫苗载体,本文就HBc核壳结构特点及其作为颗粒样免疫载体的应用作一综述。
出处
《热带医学杂志》
CAS
2004年第2期215-217,共3页
Journal of Tropical Medicine
参考文献25
-
1[1]Clarke BE,Newton SE,Carroll AR,et al,Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein [J].Nature,1987; 330:381-384.
-
2[2]Tarar MR,Emery VC,Harrison TJ.Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein[J].FEMS Immunol Med Microbiol,1996; 16(3-4): 183-192.
-
3[3]Koletzki D,Biel SS,Meisel H,et aJ.HBV core particles allow the insertion and surface exposure of the entire potentiallyprotective region of puumala hantavirus nucleocapsid protein[J].Biol Chem,1999; 380(3): 325-333.
-
4[4]Ulrich R,Koletzki D,Lachmann S,et al.New chimaeric hepatitisB virus core particle carrying hantavirus (serotype puumala)epitopes: immunogenicity and protection against virus challenge [J].J Biotechnol,1999; 73(2-3): 141-153.
-
5[5]Isaguliants MG,Nordlund S,Sallberg M,et al.HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors [J].Immunol Leu,1996;52(1):37-44.
-
6[6]Borisova G,Borschukova O,Skrastina D,et al.Behavior of a short preSl epitope on the surface of hepatitis B core particle[J].Biol Chem,1999; 380(3): 315-324.
-
7[7]Neirynck S,Deroo T,Saelens X,et al.A universal influenza A vaccine based on the extracellular domain of the M2 protein[J].Nat Mel,1999; 5(10): 1157-1163.
-
8[8]Milich DR,Hughes J,Jones J,et al.Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate[J].Vaccine,2002; 20(5-6): 771-788.
-
9[9]Bottcher B,Wynne SA,Crowther RA.Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy [J].Nature,1997; 386:88-91.
-
10[10]Pumpens P,Grens E.HBV core particles as a carrier for B cell/T cell epitopes[J].Intervirology,2001; 44(2-3): 98-114.
-
1黄锐,黄从新.中性粒细胞/淋巴细胞比值与心房颤动关系的最新研究进展[J].中国循环杂志,2016,31(4):414-416. 被引量:8
-
2黄勤,尢家騄.心肌NF-κB与疾病[J].国外医学(生理病理科学与临床分册),2000,20(3):204-206. 被引量:5
-
3曹振环(编译).基于狂犬病毒的疫苗载体可抑制猿-人免疫缺陷病毒[J].传染病网络动态,2007(6):4-4.
-
4孟兆丽,相宏宇,谢秋宏.sLOX-1:一个极具研究潜力的心血管疾病诊断生物标志物[J].中国动脉硬化杂志,2015,23(10):1061-1065. 被引量:4
-
5姜恩平,胡景鑫.一氧化氮与心肌再灌注损伤[J].北华大学学报(自然科学版),2001,2(4):314-317. 被引量:3
-
6冷萍,付义,王一帆.中医药对特发性肺间质纤维化诊治的研究进展[J].中华中医药学刊,2016,34(4):801-803. 被引量:6
-
7ShiverJW.,陈锦荣,江丽君.无复制力腺病毒疫苗载体诱导抗HIV—1免疫[J].生物制品快讯,2003(7):11-11.
-
8Schmaljohn CS,李安敏.肾综合症出血热牛痘苗载体候选疫苗的制备[J].微生物学免疫学进展,1992,20(3):34-36.
-
9谭文杰,丛郁,毕胜利,苗季,丛旭,詹美云.DNA免疫引起小鼠产生抗丙型肝炎病毒核壳区体液应答的初步研究[J].中国免疫学杂志,1998,14(6):453-455. 被引量:1
-
10田博.用乙型肝炎疫苗免疫治疗慢性乙型肝炎[J].国外医学(预防.诊断.治疗用生物制品分册),2001,24(6):249-251.